I am going forward with recommendations for treatment of my prostate cancer. Actually I have been given 4 options: Continue Active Surveillance; Focal ablation of the Gleason 3/4 tumor; Radical Prostatectomy; SBRT radiation of prostate gland.
I would appreciate any feedback on my decision to go with SBRT.
My details:
Prostate cancer (CMS code)
Staging form: Prostate, AJCC 8th Edition
- Clinical stage from 2/6/2025: Stage IIB (cT2a, cN0, cM0, PSA: 3.6, Grade Group: 2) - Unsigned
Histopathologic type: Adenocarcinoma, NOS
Prostate specific antigen (PSA) range: Less than 10
Gleason primary pattern: 3
Gleason secondary pattern: 4
Gleason score: 7
Histologic grading system: 5 grade system
70 y.o. year-old male with initially clinically localized prostate cancer (pre-treatment PSA 3.5, Gleason 3+3 with 1/14 cores positive, CAPRA 1, Oncotype 25 – low risk, Decipher 0.4 – low risk), monitored on active surveillance with subsequent prostate biopsy on 10/18/21 showing Gleason 3+4 prostate cancer (5% pattern 4 with total 6/7 positive MRI-targeted lesion, otherwise benign systematic cores) with transrectal ultrasound on 2/6/25 consistent with US T2a disease (Dr. Shinohara).
Recommendation: Either SBRT 38 Gy in 4 fraction to the prostate, radical prostatectomy (surgery), focal ablation, or continued active surveillance with Dr. Shinohara.
Plan:
[1] Re-referral for Dr. Shinohara for biopsy, GSM placement, hydrogel spacing
[2] Follow-up with Dr. Gottschalk after [1].
Tentative recommendation for Cyberknife 38Gy in 4 fractions EOD
- RT authorization will be obtained
- CT and MRI simulation will be scheduled